Terms: = Ovarian cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6
620 results:
1. Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer.
Cheng Y; Li Q; Sun G; Li T; Zou Y; Ye H; Wang K; Shi J; Wang P
Sci Rep; 2024 Apr; 14(1):9757. PubMed ID: 38684875
[TBL] [Abstract] [Full Text] [Related]
2. Bayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers.
Abrego L; Zaikin A; Marino IP; Krivonosov MI; Jacobs I; Menon U; Gentry-Maharaj A; Blyuss O
Cancer Med; 2024 Apr; 13(7):e7163. PubMed ID: 38597129
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of the Cutoff Point and Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio in Predicting ovarian cancer Compared to Pathological Findings.
Hosseini MS; Amiri F; Rezapour M; Ashraf Ganjoie T; Farzaneh F; Arab M; Talayeh M; Beheshti Rooy R; Hadi F
Asian Pac J Cancer Prev; 2024 Mar; 25(3):971-976. PubMed ID: 38546079
[TBL] [Abstract] [Full Text] [Related]
4. Enhancing precision medicine: a nomogram for predicting platinum resistance in epithelial ovarian cancer.
Li R; Xiong Z; Ma Y; Li Y; Yang Y; Ma S; Ha C
World J Surg Oncol; 2024 Mar; 22(1):81. PubMed ID: 38509620
[TBL] [Abstract] [Full Text] [Related]
5. Preoperative serum level of CA153 and a new model to predict the sub-optimal primary debulking surgery in patients with advanced epithelial ovarian cancer.
Jia Y; Jiang Y; Fan X; Zhang Y; Li K; Wang H; Ning X; Yang X
World J Surg Oncol; 2024 Feb; 22(1):64. PubMed ID: 38395933
[TBL] [Abstract] [Full Text] [Related]
6. CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.
Luo X; Mo J; Zhang M; Huang W; Bao Y; Zou R; Yao L; Yuan L
World J Surg Oncol; 2024 Feb; 22(1):44. PubMed ID: 38317230
[TBL] [Abstract] [Full Text] [Related]
7. Human Epididymis Protein 4 (he4) and cancer Antigen 125 (CA125) for Prediction of Optimal Primary Surgery in Non-Mucinous Epithelial ovarian cancer.
Promchit K; Oranratanaphan S
Asian Pac J Cancer Prev; 2024 Jan; 25(1):281-286. PubMed ID: 38285795
[TBL] [Abstract] [Full Text] [Related]
8. Noninvasive serum N-glycans associated with ovarian cancer diagnosis and precancerous lesion prediction.
Liu S; Tu C; Zhang H; Huang H; Liu Y; Wang Y; Cheng L; Liu BF; Ning K; Liu X
J Ovarian Res; 2024 Jan; 17(1):26. PubMed ID: 38281033
[TBL] [Abstract] [Full Text] [Related]
9. Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study.
Cai G; Huang F; Gao Y; Li X; Chi J; Xie J; Zhou L; Feng Y; Huang H; Deng T; Zhou Y; Zhang C; Luo X; Xie X; Gao Q; Zhen X; Liu J
Lancet Digit Health; 2024 Mar; 6(3):e176-e186. PubMed ID: 38212232
[TBL] [Abstract] [Full Text] [Related]
10. Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Young Han C; Bedia JS; Yang WL; Hawley SJ; Bergan L; Hopper M; Celestino J; Guo J; Gornet TG; Soosaipillai A; Yang H; Doskocil SD; Lokshin AE; Handy BC; Diamandis EP; Moore RG; Lu KH; Lu Z; Anderson KS; Drescher CW; Skates SJ; Bast RC
Br J Cancer; 2024 Mar; 130(5):861-868. PubMed ID: 38195887
[TBL] [Abstract] [Full Text] [Related]
11. Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, he4, and C5a.
Shi H; Liu L; Deng X; Xing X; Zhang Y; Djouda Rebecca Y; Han L
J Ovarian Res; 2024 Jan; 17(1):4. PubMed ID: 38178252
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of he4 in advanced-stage, high-grade serous ovarian cancer: Analysis of he4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125.
AlSomairi A; Himayda S; Altelmesani A; Lee YJ; Lee JY
Gynecol Oncol; 2024 Feb; 181():155-161. PubMed ID: 38176127
[TBL] [Abstract] [Full Text] [Related]
13. D-dimer, Fibrinogen and Tumor Marker Levels in Patients with benign and Malignant ovarian Tumors.
Farzaneh F; Salimnezhad M; Hosseini MS; Ashraf Ganjouee T; Arab M; Talayeh M
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4263-4268. PubMed ID: 38156862
[TBL] [Abstract] [Full Text] [Related]
14. Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer.
Wang H; Chen C; Wang D; Zhu Y; Chen P
BMC Cancer; 2023 Dec; 23(1):1210. PubMed ID: 38066448
[TBL] [Abstract] [Full Text] [Related]
15. Serum human epididymis protein 4 is associated with disease severity in patients with IgA nephropathy.
Luo HL; He C; Xue H; Li M; Ji L; Xia Y
Clin Biochem; 2024 Jan; 123():110701. PubMed ID: 38048899
[TBL] [Abstract] [Full Text] [Related]
16. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
17. A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, he4, mesothelin).
Klotz DM; Link T; Wimberger P; Kuhlmann JD
Clin Chem Lab Med; 2024 Feb; 62(3):530-539. PubMed ID: 37816681
[TBL] [Abstract] [Full Text] [Related]
18. The Role of Interleukin 6 (IL6), cancer Antigen-125 (CA-125), and Human Epididymis Protein 4 (he4) to predict tumor resectability in the advanced epithelial ovarian cancer patients.
Muhammad S; Azwan RJ; Rita RS; Susanti R; Yusrawati
PLoS One; 2023; 18(10):e0292282. PubMed ID: 37792745
[TBL] [Abstract] [Full Text] [Related]
19. Revised Cut-Off Value of Human Epididymis Protein 4 Enhances Its Use as an ovarian Tumor Marker.
Machida H; Hirakawa T; Tsunekawa K; Kimura T; Murakami M; Abe Y
Gynecol Obstet Invest; 2023; 88(6):349-358. PubMed ID: 37788640
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer.
Tan X; Zou S; Chen H; Chen D
J Int Med Res; 2023 Sep; 51(9):3000605231200267. PubMed ID: 37756606
[TBL] [Abstract] [Full Text] [Related]
[Next]
